news

news

News from the Lab (news.myScience.ch)

  • News from the Lab’ is a selection of scientific works that are significant or interesting for a broad readership. 
  • The selection of news is made by the team of myScience.ch. There is no right to be published or automatic publishing.
  •  RSS Feeds (Add this page to your bookmarks)
« BACK

Pharmacology



Results 61 - 67 of 67.


Life Sciences - Pharmacology - 30.01.2019
New Findings About Anti-Malaria Drug
New Findings About Anti-Malaria Drug
01/30/2019 Researchers at the Rudolf Virchow Center of the University of Würzburg have unveiled the molecular effectiveness of artemisinins. The findings could lead to drugs for diseases such as Alzheimer's, schizophrenia and epilepsy. Artemisinin is derived from the leaves and flowers of the annual mugwort (Artemisia annua) and has been used in traditional Chinese medicine for centuries.

Chemistry - Pharmacology - 22.01.2019
Chemists develop new synthesis method for producing fluorinated piperidines
Chemists develop new synthesis method for producing fluorinated piperidines
Synthetic molecules are essential for many products in our lives: medicines, crop protection agents or special materials such as Teflon. These molecules have several components, which can be combined in a variety of ways, resulting in different properties. Both so-called piperidines and fluorinated groups are particularly important.

Pharmacology - Life Sciences - 21.01.2019
Opioids: no effect without side effect
Opioids: no effect without side effect
Pharmacologists have succeeded in almost completely suppressing the development of opioid tolerance Through genetic changes to the opioid receptor in mice, pharmacologists at Jena University Hospital have succeeded in almost completely suppressing the development of opioid tolerance. The pain-relieving effect actually improved and continued even when the drug was administered for longer periods.

Pharmacology - Life Sciences - 08.01.2019
Anticancer Drugs Formed through Molecular Evolution
Scientists at Freie Universität Explore Alternative Routes to Drugs against Tumor Cells / Findings published in online journal "Nature Communications" No 002/2019 from Jan 08, 2019 Scientists at Freie Universität Berlin have discovered an alternative route to drugs against tumor cells. The group led by Jörg Rademann from the Institute of Pharmacy examined the protein STAT5, which is responsible for the aggressive growth of human leukemia cells.

Health - Pharmacology - 02.10.2018
Why vitamin E effect often a matter of luck until now
Why vitamin E effect often a matter of luck until now
Pharmacists and biochemists of the Friedrich Schiller University Jena, together with an international research team, have decoded the anti-inflammatory mechanism of vitamin E and its metabolites. The result shows value of personalised medicine. A patented drug candidate now being studied further.. It is reputed to stop skin from aging, reduce joint degeneration in rheumatism and arthritis, and even protect against cancer and cardiovascular diseases.

Chemistry - Pharmacology - 20.08.2015
Arylboronates made easy
Arylboronates made easy
08/20/2015 Abandoning expensive and toxic materials in chemical synthesis: This is the goal pursued by scientists at the University of Würzburg. In the magazine "Angewandte Chemie", they describe a new way to achieve this goal, a surprise included. Arylboronates are important base materials for the industrial fabrication of countless products, including pharmaceutical drugs, chemicals for agriculture or liquid crystals for displays.

Chemistry - Pharmacology - 17.06.2015
First complexation of multiple CO molecules to a non-metal atom
06/17/2015 For the first time, Würzburg scientists have successfully bound multiple carbon monoxide molecules to the main group element boron. They report on their work in the latest issue of the scientific journal Nature. Scientists of Professor Holger Braunschweig's team of the Institute of Inorganic Chemistry at the University of Würzburg have successfully bound two carbon monoxide molecules (CO) to the main group element boron in a direct synthesis for the first time.